[Preventive surgical prcedures for inherited risk of breast cancer]
- PMID: 16358615
[Preventive surgical prcedures for inherited risk of breast cancer]
Abstract
Preventive surgical procedures for inherited risk of breast cancer Forwomen with a demonstrated BRCA1 or BRCA2 mutation, the cumulative risk of developing invasive breast cancer before the age of 70 years is about 50-85% and the risk of developing invasive epithelial ovarian cancer is 20-60%. Regular surveillance including physical examination and imaging is offered to mutation carriers and the options for risk-reducing surgery are discussed. Although bilateral prophylactic mastectomy is a drastic intervention, it significantly reduces the incidence of breast cancer. For mutation carriers with breast cancer, the decision to combine risk-reducing surgery with treatment is determined by the TNM stage of the disease. Prophylactic bi- or contralateral mastectomy after previous treatment for unilateral breast cancer reduces the incidence of contralateral breast cancer, but has no impact on survival. The complexity of the problem demands a multidisciplinary approach within the context of a family cancer clinic.
Similar articles
-
Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer.Ann Surg. 2010 Mar;251(3):488-92. doi: 10.1097/SLA.0b013e3181c3c36d. Ann Surg. 2010. PMID: 20134318
-
Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.Cancer. 2006 Dec 15;107(12):2745-51. doi: 10.1002/cncr.22352. Cancer. 2006. PMID: 17109443
-
Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.Cancer. 2003 Jan 1;97(1):1-11. doi: 10.1002/cncr.11048. Cancer. 2003. PMID: 12491499
-
The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations.Ann Surg Oncol. 2008 Jan;15(1):21-33. doi: 10.1245/s10434-007-9612-4. Epub 2007 Oct 17. Ann Surg Oncol. 2008. PMID: 17940826 Review.
-
Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation.Clin Genet. 2008 May;73(5):474-9. doi: 10.1111/j.1399-0004.2008.00988.x. Epub 2008 Mar 12. Clin Genet. 2008. PMID: 18341607 Review.
Cited by
-
Group medical visits in the follow-up of women with a BRCA mutation: design of a randomized controlled trial.BMC Womens Health. 2011 Aug 24;11:39. doi: 10.1186/1472-6874-11-39. BMC Womens Health. 2011. PMID: 21864353 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous